Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes

• Status: Completed
• Trial end date: 2008-01-01

Summary

This study is designed to assess the potential mechanism of action by which WelChol® (colesevelam) may improve blood glucose control in patients with type 2 diabetes

• Phase: Phase 2

Details

• Lead Sponsor: Daiichi Sankyo Inc.; Daiichi Sankyo, Inc.
• Treatments: Colesevelam Hydrochloride; Insulin; Insulin Glargine; Insulin, Globin Zinc